Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Sarcoma × eribulin × Clear all

Phase

Status

Sponsor Class

INDUSTRY 7 OTHER 6 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Solitary Fibrous Tumors 1 Sarcoma 1 Breast Neoplasms 1

Interventions

Ifosfamide 18 Doxorubicin 18 Filgrastim 16 Radiotherapy 12 Vincristine 10 Cyclophosphamide 10 Cisplatin 9 Etoposide 8 Trabectedin 7 Granulocyte Colony-Stimulating Factor 7 Gene Expression Profiling 7 Polymerase Chain Reaction 6 Dactinomycin 6 sargramostim 5 etoposide phosphate 5 Paclitaxel 5 Mesna 4 Chemotherapy, Adjuvant 4 Brachytherapy 4 pegfilgrastim 3 Topotecan 3 Microarray Analysis 3 Irinotecan 3 Immunohistochemistry 3 Gemcitabine 3 Dexrazoxane 3 Base Sequence 3 olaparib 2 brostallicin 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03840772 2024-09-20

ERASING

Italian Sarcoma Group

Phase 2 Completed

Sarcoma, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡